SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-015573
Filing Date
2019-08-26
Accepted
2019-08-26 08:30:58
Documents
14
Period of Report
2019-08-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm   iXBRL 8-K 44051
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY ex99_1.htm EX-99.1 14598
  Complete submission text file 0001140361-19-015573.txt   255381

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20190825.xsd EX-101.SCH 5196
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20190825_def.xml EX-101.DEF 18671
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20190825_lab.xml EX-101.LAB 28869
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20190825_pre.xml EX-101.PRE 20971
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 7312
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 191050610
SIC: 2834 Pharmaceutical Preparations